Morphochem AG
Munich
About Morphochem AG
Morphochem has set out to introduce an innovative intravenous therapy for CDI, based on a novel antibacterial: MCB3681. We are truly excited about this opportunity to fill an unmet medical need and make a difference for CDI patients.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: M&A
- Last round: Series Unknown (Jan 1998)
- Website: morphochem.de
- Phone: 498978005555
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/morphochem-ag-2160881 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.